Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
- PMID: 37169596
- PMCID: PMC10519407
- DOI: 10.1101/gr.277585.122
Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
Abstract
Killer cell immunoglobulin like receptor (KIR) genes and human leukocyte antigen (HLA) genes play important roles in innate and adaptive immunity. They are highly polymorphic and cannot be genotyped with standard variant calling pipelines. Compared with HLA genes, many KIR genes are similar to each other in sequences and may be absent in the chromosomes. Therefore, although many tools have been developed to genotype HLA genes using common sequencing data, none of them work for KIR genes. Even specialized KIR genotypers could not resolve all the KIR genes. Here we describe T1K, a novel computational method for the efficient and accurate inference of KIR or HLA alleles from RNA-seq, whole-genome sequencing, or whole-exome sequencing data. T1K jointly considers alleles across all genotyped genes, so it can reliably identify present genes and distinguish homologous genes, including the challenging KIR2DL5A/KIR2DL5B genes. This model also benefits HLA genotyping, where T1K achieves high accuracy in benchmarks. Moreover, T1K can call novel single-nucleotide variants and process single-cell data. Applying T1K to tumor single-cell RNA-seq data, we found that KIR2DL4 expression was enriched in tumor-specific CD8+ T cells. T1K may open the opportunity for HLA and KIR genotyping across various sequencing applications.
© 2023 Song et al.; Published by Cold Spring Harbor Laboratory Press.
Figures


Similar articles
-
kir-mapper: A Toolkit for Killer-Cell Immunoglobulin-Like Receptor (KIR) Genotyping From Short-Read Second-Generation Sequencing Data.HLA. 2025 Mar;105(3):e70092. doi: 10.1111/tan.70092. HLA. 2025. PMID: 40095784
-
In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales.Brief Bioinform. 2021 May 20;22(3):bbaa223. doi: 10.1093/bib/bbaa223. Brief Bioinform. 2021. PMID: 32940337 Free PMC article.
-
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.Am J Hum Genet. 2016 Aug 4;99(2):375-91. doi: 10.1016/j.ajhg.2016.06.023. Am J Hum Genet. 2016. PMID: 27486779 Free PMC article.
-
Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.Tissue Antigens. 2008 Jul;72(1):11-20. doi: 10.1111/j.1399-0039.2008.01050.x. Epub 2008 May 20. Tissue Antigens. 2008. PMID: 18498296
-
KIR2DL5 alleles mark certain combination of activating KIR genes.Genes Immun. 2008 Jul;9(5):470-80. doi: 10.1038/gene.2008.39. Epub 2008 May 29. Genes Immun. 2008. PMID: 18509341
Cited by
-
Comprehensive genome analysis and variant detection at scale using DRAGEN.Nat Biotechnol. 2025 Jul;43(7):1177-1191. doi: 10.1038/s41587-024-02382-1. Epub 2024 Oct 25. Nat Biotechnol. 2025. PMID: 39455800 Free PMC article.
-
Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes.Cell Rep. 2025 Apr 22;44(4):115425. doi: 10.1016/j.celrep.2025.115425. Epub 2025 Mar 19. Cell Rep. 2025. PMID: 40117290 Free PMC article.
-
Full resolution HLA and KIR genes annotation for human genome assemblies.bioRxiv [Preprint]. 2024 Jan 23:2024.01.20.576452. doi: 10.1101/2024.01.20.576452. bioRxiv. 2024. Update in: Genome Res. 2024 Nov 20;34(11):1931-1941. doi: 10.1101/gr.278985.124. PMID: 38328160 Free PMC article. Updated. Preprint.
-
MHConstructor: a high-throughput, haplotype-informed solution to the MHC assembly challenge.Genome Biol. 2024 Oct 17;25(1):274. doi: 10.1186/s13059-024-03412-6. Genome Biol. 2024. PMID: 39420419 Free PMC article.
-
kir-mapper: A Toolkit for Killer-Cell Immunoglobulin-Like Receptor (KIR) Genotyping From Short-Read Second-Generation Sequencing Data.HLA. 2025 Mar;105(3):e70092. doi: 10.1111/tan.70092. HLA. 2025. PMID: 40095784
References
-
- Bhatt RS, Berjis A, Konge JC, Mahoney KM, Klee AN, Freeman SS, Chen C-H, Jegede OA, Catalano PJ, Pignon J-C, et al. 2021. KIR3DL3 is an inhibitory receptor for HHLA2 that mediates an alternative immunoinhibitory pathway to PD1. Cancer Immunol Res 9: 156–169. 10.1158/2326-6066.CIR-20-0315 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous